» Articles » PMID: 7693744

Efficient Production of Antigenic Mosaic Reassortants of Rotavirus with the Aid of Anti-VP4 and Anti-VP7 Neutralizing Monoclonal Antibodies

Overview
Journal J Virol Methods
Specialty Microbiology
Date 1993 Sep 1
PMID 7693744
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Anti-VP4 and anti-VP7 neutralizing monoclonal antibodies (N-MAbs) were used to select efficiently antigenic mosaic reassortants of rotavirus whose VP4 and VP7 are derived from parental strains having different antigenic specificities of VP4 and VP7. Under the selective pressure of anti-simian rotavirus (SA11) VP7 N-MAb and anti-human rotavirus (Wa or S2) VP4 N-MAb, all the clones isolated after mixed infection with SA11 and human rotavirus were found to be reassortants having VP4 of SA11 and VP7 of Wa or S2 by serological and genomic analyses. Two reassortants isolated from the mixed infection with SA11 and S2 had a segment whose different migration in polyacrylamide gel was different from those of any RNA segments of the parent strains, suggesting the occurrence of rearrangement in the process of reassortment.

Citing Articles

Human Rotavirus Reverse Genetics Systems to Study Viral Replication and Pathogenesis.

Komoto S, Fukuda S, Murata T, Taniguchi K Viruses. 2021; 13(9).

PMID: 34578372 PMC: 8473093. DOI: 10.3390/v13091791.


Acrylamide concentration affects the relative position of VP7 gene of serotype G2 strains as determined by polyacrylamide gel electrophoresis.

Ross J, Ostlund E, Cao D, Tatsumi M, Hoshino Y J Clin Virol. 2008; 42(4):374-80.

PMID: 18457989 PMC: 2574723. DOI: 10.1016/j.jcv.2008.03.019.


Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection.

Gorrell R, Bishop R Clin Diagn Lab Immunol. 1997; 4(5):509-14.

PMID: 9302196 PMC: 170582. DOI: 10.1128/cdli.4.5.509-514.1997.


Effect of the selection pressure with anti-VP7 and anti-VP4 neutralizing monoclonal antibodies on reassortant formation between two human rotaviruses.

Kobayashi N, Taniguchi K, Urasawa T, URASAWA S Arch Virol. 1994; 135(3-4):383-96.

PMID: 7802855 DOI: 10.1007/BF01310022.


A retrospective analysis of the prevalence of HIV seropositivity and its demographics in the normal healthy volunteer population of a phase-I clinical drug study unit.

Jagathesan R, Lewis L, Mant T Br J Clin Pharmacol. 1995; 39(4):463-4.

PMID: 7640158 PMC: 1365139. DOI: 10.1111/j.1365-2125.1995.tb04480.x.